Previous 10 | Next 10 |
2024-02-13 08:28:58 ET More on premarket losers Arm Holdings: Irrational Exuberance To The Max Arm Holdings: Shares Surge As GenAI Momentum Drives Massive Earnings Beat Arm Holdings: Why The Fiscal Q3 Earnings Foretell Change Arm Holdings surges as investors ...
2024-02-13 07:04:47 ET More on InMode InMode: Take The Plunge Before It Goes Into Beast Mode InMode: Good Margin Of Safety At Current Levels InMode: Despite Attractive Valuation, I Believe It's Premature To Dive In - Here's Why InMode Q4 2023 Earnings Preview...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
2024-02-12 11:37:12 ET More on InMode InMode: Take The Plunge Before It Goes Into Beast Mode InMode: Good Margin Of Safety At Current Levels InMode: Despite Attractive Valuation, I Believe It's Premature To Dive In - Here's Why InMode rises after issuing guid...
2024-02-04 13:30:00 ET Summary InMode stock has consolidated constructively but has not experienced the renewed enthusiasm observed in other med tech stocks. Near-term headwinds are expected to persist for INMD due to its specialization in aesthetics. Management offered tepid guid...
2024-01-30 18:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-21 03:49:13 ET Summary InMode's stock valuation has fluctuated over time, with high multiples in 2021 due to impressive growth. The company's growth has since slowed down as it has matured. However, current multiples seem perhaps too punishing, with short-term possible...
2024-01-19 20:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-16 07:29:15 ET More on InMode InMode: Despite Attractive Valuation, I Believe It's Premature To Dive In - Here's Why InMode Is Inherently Undervalued - Bullish Support Observed InMode: A Deep Analysis Into Its Mixed Picture Inmode stock slides after m...
InMode to Report Fourth Quarter & Full Year 2023 Financial Results and Hold Conference Call on Feb. 13, 2024, Expects Q4 Revenue Between $126.0M-$126.5M InMode to Report Fourth Quarter & Full Year 2023 Financial Results and Hold Conference Call on Feb. 13, 2024, Expects Q4 Reven...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...